Literature DB >> 8741774

The changing epidemiology of smoking and lung cancer histology.

E L Wynder1, J E Muscat.   

Abstract

In 1950, the first large-scale epidemiological studies demonstrated that lung cancer is causatively associated with cigarette smoking, a finding subsequently confirmed by the Royal College of Physicians in London, the U.S. Surgeon General, and the World Health Organization. Although cigarette consumption has gradually decreased in the United States from a high of about 3800 cigarettes per adult per year in 1965 to about 2800 cigarettes in 1993, death from lung cancer has reached a high among males at the rate of 74.9/100,000/year and among females at the rate of 28.5. However, in the younger cohorts, the lung cancer death rate is decreasing in both men and women. In this overview we discuss the steeper increase during recent decades of lung adenocarcinoma incidence compared with squamous cell carcinoma of the lung. In 1950, the ratio of these two major types of lung cancer in males was about 1:18; today it is about 1:1.2-1.4. This overview discusses two concepts that are regarded as contributors to this change in the histological types of lung cancer. One factor is the decrease in average nicotine and tar delivery of cigarettes from about 2.7 and 38 mg in 1955 to 1.0 and 13.5 mg in 1993, respectively. Other major factors for the reduced emission of smoke relate to changes in the composition of the cigarette tobacco blend and general acceptance of cigarettes with filter tips; the latter constitute 97% of all cigarettes currently sold. However, smokers of low-yield cigarettes compensate for the low delivery of nicotine by inhaling the smoke more deeply and by smoking more intensely; such smokers may be taking up to 5 puffs/min with puff volumes up to 55 ml. Under these conditions, the peripheral lung is exposed to increased amounts of smoke carcinogens that are suspected to lead to lung adenocarcinoma. Among the important changes in the composition of the tobacco blend of the U.S. cigarette is a significant increase in nitrate content (0.5% to 1.2-1.5%), which raises the yields of nitrogen oxides and N-nitrosamines in the smoke. Furthermore, the more intense smoking by the consumers of low-yield cigarettes increases N-nitrosamines in the smoke 2- to 3-fold. Among the N-nitrosamines is 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a powerful lung carcinogen in animals that is exclusively formed from nicotine. This organ-specific tobacco-specific nitrosamine (TSNA) induces adenocarcinoma of the lung. All of these factors, the more intense smoking, the deeper inhalation of the smoke, and the increased yields of N-nitrosamines in the smoke of low-yield cigarettes, are considered major contributors to the drastic increase in lung adenocarcinoma among cigarette smokers in recent years. This overview also discusses the differences in the major lung cancer types in female compared with male smokers as well as the likely underlying factors for increased lung cancer risk among African Americans compared with that among white Americans. Although the only sure way to prevent smoking-related diseases is giving up the tobacco habit, there must be a measure of protection for those who cannot accomplish this. Therefore, setting upper permissible limits of tar levels for the smoke of U.S. cigarettes, similar to strategies already taken in Western Europe, should be considered.

Entities:  

Mesh:

Year:  1995        PMID: 8741774      PMCID: PMC1518964          DOI: 10.1289/ehp.95103s8143

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  46 in total

1.  Lung cancer among cigar and pipe smokers.

Authors:  I T Higgins; C M Mahan; E L Wynder
Journal:  Prev Med       Date:  1988-01       Impact factor: 4.018

2.  Absorption of nicotine in cigarette and cigar smoke through the oral mucosa.

Authors:  A K Armitage; D M Turner
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  Estimating the yield to smokers of tar, nicotine, and carbon monoxide from the 'lowest yield' ventilated filter-cigarettes.

Authors:  L T Kozlowski; W S Rickert; M A Pope; J C Robinson; R C Frecker
Journal:  Br J Addict       Date:  1982-06

4.  Variations in the reporting of menstrual histories.

Authors:  J A Bean; J D Leeper; R B Wallace; B M Sherman; H Jagger
Journal:  Am J Epidemiol       Date:  1979-02       Impact factor: 4.897

5.  Impact of long-term filter cigarette usage on lung and larynx cancer risk: a case-control study.

Authors:  E L Wynder; S D Stellman
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

6.  Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group.

Authors:  J D Cox; R A Yesner
Journal:  Am Rev Respir Dis       Date:  1979-11

7.  Sex steroid receptors in diverse human tumors.

Authors:  S Kobayashi; T Mizuno; N Tobioka; H Ichimura; T Samoto; H Tanaka; A Masaoka; S Wakabayashi; S Umemura; H Fukuoka; H Nagai
Journal:  Gan       Date:  1982-06

8.  Lung cancer in nonsmokers.

Authors:  G C Kabat; E L Wynder
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

9.  The changing histopathology of lung cancer: a review of 1682 cases.

Authors:  R G Vincent; J W Pickren; W W Lane; I Bross; H Takita; L Houten; A C Gutierrez; T Rzepka
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

10.  Steroid receptors in human lung cancer cytosols.

Authors:  P K Chaudhuri; P A Thomas; M J Walker; H A Briele; T K Das Gupta; C W Beattie
Journal:  Cancer Lett       Date:  1982-09       Impact factor: 8.679

View more
  54 in total

1.  The National Lung Screening Trial: overview and study design.

Authors:  Denise R Aberle; Christine D Berg; William C Black; Timothy R Church; Richard M Fagerstrom; Barbara Galen; Ilana F Gareen; Constantine Gatsonis; Jonathan Goldin; John K Gohagan; Bruce Hillman; Carl Jaffe; Barnett S Kramer; David Lynch; Pamela M Marcus; Mitchell Schnall; Daniel C Sullivan; Dorothy Sullivan; Carl J Zylak
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

2.  Targeted therapies for locally advanced or metastatic squamous cell carcinoma of the lung.

Authors:  Thomas E Stinchcombe
Journal:  Curr Treat Options Oncol       Date:  2013-12

3.  Has the lung cancer risk from smoking increased over the last fifty years?

Authors:  David M Burns; Christy M Anderson; Nigel Gray
Journal:  Cancer Causes Control       Date:  2010-12-25       Impact factor: 2.506

4.  The consequences of the unregulated cigarette.

Authors:  Nigel Gray
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

5.  Reducing levels of toxic chemicals in cigarette smoke: a new Healthy People 2010 objective.

Authors:  Patricia Richter; Terry Pechacek; Monica Swahn; Victoria Wagman
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

6.  Use of multiple surveys to estimate mortality among never, current, and former smokers: changes over a 20-year interval.

Authors:  W L Rosenbaum; T D Sterling; J J Weinkam
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

7.  Quantification of DNA Lesions Induced by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Mammalian Cells.

Authors:  Su Guo; Jiapeng Leng; Ying Tan; Nathan E Price; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2019-02-15       Impact factor: 3.739

8.  Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer.

Authors:  Hildegard M Schuller
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 9.  It's all about sex: gender, lung development and lung disease.

Authors:  Michelle A Carey; Jeffrey W Card; James W Voltz; Samuel J Arbes; Dori R Germolec; Kenneth S Korach; Darryl C Zeldin
Journal:  Trends Endocrinol Metab       Date:  2007-08-30       Impact factor: 12.015

10.  Smoking and the risk of upper aero digestive tract cancers for men and women in the Asia-Pacific region.

Authors:  Alireza Ansary-Moghaddam; Alexandra Martiniuk; Tai-Hing Lam; Konrad Jamrozik; Akiko Tamakoshi; Xianghua Fang; Il Suh; Federica Barzi; Rachel Huxley; Mark Woodward
Journal:  Int J Environ Res Public Health       Date:  2009-04-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.